Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Adenosquamous × Albumin-Bound Paclitaxel × 1 year × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 40 Triple Negative Breast Neoplasms 17 Breast Neoplasms 16 Carcinoma, Non-Small-Cell Lung 13 Squamous Cell Carcinoma of Head and Neck 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Neoplasm Metastasis 6 Lung Neoplasms 6 Esophageal Neoplasms 6 Stomach Neoplasms 5 Ovarian Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Cholangiocarcinoma 4 Gallbladder Neoplasms 3 Fallopian Tube Neoplasms 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Adenocarcinoma 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Recurrence 2 Rectal Neoplasms 2 Pancreatic Adenocarcinoma 2 Colonic Neoplasms 2 Carcinoma, Pancreatic Ductal 2 Carcinoma, Hepatocellular 2 Carcinoma 2 Biliary Tract Neoplasms 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1

Interventions

11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡